Drugs
1
in active trials · 2 in all
Trials
1 active
7 since 2021
Drugs1
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Soluble LAG-3 protein (immune activator) |
Phase 3 | Jun 2027Phase 3 trial completes | |||
| Next date | Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC) | ||||
| Open drug page | |||||
About
- No active trial
- IMP761
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021 · Logos provided by Logo.dev